TG Therapeutics, Inc. (TGTX) Stock Overview
NASDAQ · Healthcare · Biotechnology
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About TG Therapeutics, Inc.
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally. The company provides BRIUMVI, an anti-CD20 monoclonal antibody for the…
Source: Yahoo Finance
Sector & Industry
TG Therapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry group. It is listed on the NASDAQ exchange.
TG Therapeutics, Inc. at a Glance
| Company | TG Therapeutics, Inc. |
| Ticker | TGTX |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $55.98 |
| Market cap | $8.57B |
| P/E ratio (trailing) | 20.43 |
| EPS (trailing) | $2.74 |
| 52-week high | $59.30 |
| 52-week low | $26.76 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 1.66 |
| Return on equity (ROE) | 100.28% |
| Debt-to-equity | 124.89% |
| Average volume | 2.44M |
| Shares outstanding | 153.08M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 399 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Frequently Asked Questions
- What is TG Therapeutics, Inc.'s current P/E ratio?
- TG Therapeutics, Inc. (TGTX) has a trailing P/E ratio of 20.43 as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is TG Therapeutics, Inc.'s market capitalisation?
- TG Therapeutics, Inc.'s market cap is $8.57B based on our latest snapshot. See how it ranks by market cap →
- What is TGTX's 52-week range?
- Over the past 52 weeks, TGTX has traded between $26.76 and $59.30. What does the 52-week range mean? →
- How volatile is TG Therapeutics, Inc. compared to the market?
- TG Therapeutics, Inc. has a beta of 1.66, meaning it has historically moved more than the broader market. What does beta measure? →
- Does TG Therapeutics, Inc. pay a dividend?
- TG Therapeutics, Inc. does not currently pay a dividend according to our latest data.
- What exchange is TGTX listed on?
- TGTX is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is TG Therapeutics, Inc. in?
- TG Therapeutics, Inc. is classified in the Healthcare sector. Compare with Healthcare peers →
Need to convert currencies or units alongside this data? Our quick conversion tools are always on hand.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →Philip Fisher on what makes a business worth owning for the long term.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →